FibroGen Net Income
| FGENDelisted Stock | USD 9.22 0.29 3.05% |
As of the 14th of February 2026, FibroGen shows the Standard Deviation of 4.1, coefficient of variation of (2,085), and Mean Deviation of 2.66. FibroGen technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
FibroGen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing FibroGen's valuation are provided below:FibroGen does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. FibroGen |
Search Suggestions
| FG | FG Annuities Life | Company |
| FGBIP | First Guaranty Bancshares | Company |
| FGWMX | Fidelity New Markets | Mutual Fund |
| FGD | First Trust Dow | ETF |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, FibroGen reported net income of (47.58 Million). This is 113.94% lower than that of the Biotechnology sector and 167.93% lower than that of the Health Care industry. The net income for all United States stocks is 108.33% higher than that of the company.
FibroGen Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FibroGen's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FibroGen could also be used in its relative valuation, which is a method of valuing FibroGen by comparing valuation metrics of similar companies.FibroGen is currently under evaluation in net income category among its peers.
FibroGen Fundamentals
| Return On Equity | -10.16 | |||
| Return On Asset | -0.18 | |||
| Profit Margin | 25.99 % | |||
| Operating Margin | (4.99) % | |||
| Current Valuation | 86.86 M | |||
| Shares Outstanding | 4.05 M | |||
| Shares Owned By Insiders | 1.65 % | |||
| Shares Owned By Institutions | 28.00 % | |||
| Number Of Shares Shorted | 131.34 K | |||
| Price To Earning | 97.67 X | |||
| Price To Book | 53.83 X | |||
| Price To Sales | 4.40 X | |||
| Revenue | 29.62 M | |||
| Gross Profit | (30.35 M) | |||
| EBITDA | (142.43 M) | |||
| Net Income | (47.58 M) | |||
| Cash And Equivalents | 438.13 M | |||
| Cash Per Share | 4.67 X | |||
| Total Debt | 90.17 M | |||
| Debt To Equity | 0.89 % | |||
| Current Ratio | 2.17 X | |||
| Book Value Per Share | (4.21) X | |||
| Cash Flow From Operations | (138 M) | |||
| Short Ratio | 3.20 X | |||
| Earnings Per Share | (12.85) X | |||
| Target Price | 43.0 | |||
| Number Of Employees | 225 | |||
| Beta | 0.77 | |||
| Market Capitalization | 36.49 M | |||
| Total Asset | 214.53 M | |||
| Retained Earnings | (1.89 B) | |||
| Working Capital | 63.2 M | |||
| Current Asset | 200.56 M | |||
| Current Liabilities | 67.18 M | |||
| Net Asset | 214.53 M |
About FibroGen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FibroGen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FibroGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FibroGen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with FibroGen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if FibroGen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FibroGen will appreciate offsetting losses from the drop in the long position's value.Moving together with FibroGen Stock
Moving against FibroGen Stock
| 0.78 | GS | Goldman Sachs Group | PairCorr |
| 0.72 | USPH | US Physicalrapy | PairCorr |
| 0.7 | CYCC | Cyclacel Pharmaceuticals Symbol Change | PairCorr |
| 0.66 | TOGOF | TomaGold | PairCorr |
| 0.66 | EMMA | Emmaus Life Sciences | PairCorr |
The ability to find closely correlated positions to FibroGen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace FibroGen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back FibroGen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling FibroGen to buy it.
The correlation of FibroGen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as FibroGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if FibroGen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for FibroGen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in FibroGen Stock
If you are still planning to invest in FibroGen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FibroGen's history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |